| SpectraBase Spectrum ID |
GUOfPEGst3Q |
| Name |
DMBA-CHMINACA TMS |
| Classification |
Indazole cannabinoid designer drug derivative |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
443.260418595 u |
| Formula |
C24H37N3O3Si |
| InChI |
InChI=1S/C24H37N3O3Si/c1-24(2,3)21(23(29)30-31(4,5)6)25-22(28)20-18-14-10-11-15-19(18)27(26-20)16-17-12-8-7-9-13-17/h10-11,14-15,17,21H,7-9,12-13,16H2,1-6H3,(H,25,28) |
| InChIKey |
IMSVRNGTMBQGCW-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
443.663 g/mol |
| Nominal Mass |
443 u |
| Quality |
995 |
| Retention Index |
2910 |
| SMILES |
C=1(C=2C(N(N1)CC1CCCCC1)=CC=CC2)C(NC(C(C)(C)C)C(O[Si](C)(C)C)=O)=O |
| SPLASH |
splash10-002g-2696000000-d14a92ba37345892d5ea |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
MDMB-CHMINACA acid TMS
trimethylsilyl 2-(((1-(cyclohexylmethyl)-1H-indazol-3-yl)carbonyl)amino)-3,3-dimethylbutanoate |
| Technique |
GC/MS |
| Wiley ID |
DD2024_025457 |
